3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Leukemia, Myeloid, Acute
2
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
2
Hematologic Neoplasms
2
Ganglioneuroblastoma
2
Recurrence
1
Neuroblastoma
1
Myelodysplastic Syndromes
1
Medulloblastoma
1
Lymphoma, Non-Hodgkin
1
Leukemia, Myelomonocytic, Juvenile
1
Leukemia, Myelomonocytic, Chronic
1
Leukemia, Myeloid, Accelerated Phase
1
Leukemia, Large Granular Lymphocytic
1
Leukemia, Biphenotypic, Acute
1
Hodgkin Disease
1
Blastic Plasmacytoid Dendritic Cell Neoplasm
1
Blast Crisis
1
Anemia, Refractory, with Excess of Blasts
1
Interventions
pembrolizumab
16
Bevacizumab
11
Carboplatin
10
Nivolumab
8
Pemetrexed
7
Temozolomide
6
atezolizumab
5
Standard of Care
5
Prednisone
5
Exercise
5
Cyclophosphamide
5
Cetuximab
5
durvalumab
4
abemaciclib
4
Paclitaxel
4
Dexamethasone
4
Cisplatin
4
Blood Specimen Collection
4
dostarlimab
3
daratumumab
3
cabozantinib
3
Rituximab
3
Oxaliplatin
3
Metformin
3
Leucovorin
3
Lenalidomide
3
Ipilimumab
3
Fluorouracil
3
Doxorubicin
3
Docetaxel
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Neoplasms
×
Thiotepa
×
30 days
×
Clear all
No trials found.